240 related articles for article (PubMed ID: 36193493)
1. Meta-Analysis of Efficacy and Safety of Karelizumab Combined with Apatinib in the Treatment of Advanced Gastric Cancer.
Liu H; Li Y; Yao Y; Chen K; Gan J
Dis Markers; 2022; 2022():6971717. PubMed ID: 36193493
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of safety and efficacy of apatinib combination with chemotherapy for ovarian cancer treatment: a systematic review and meta-analysis.
Qi J; Liu E; Yue H; Chen G; Liu Y; Chen J
Ann Palliat Med; 2021 Sep; 10(9):9902-9913. PubMed ID: 34551570
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Low-Dose Apatinib Combined with Chemotherapy as Second-Line Treatment for Advanced Gastric Cancer: A Meta-Analysis.
Wang L; Li J; Chen H
Chemotherapy; 2024; 69(1):11-22. PubMed ID: 37339610
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
Chen H; Xue L; Liu L; Li P
J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
[TBL] [Abstract][Full Text] [Related]
5. Clinical Efficacy, Survival, and Adverse Reaction Evaluation of Immune Checkpoint Inhibitor in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
Zhang P; Zhang X; Zhu N; Zhuang F; Zhou D; Wang P
Comput Math Methods Med; 2022; 2022():6998090. PubMed ID: 36050997
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysis.
Ma JT; Sun J; Sun L; Zhang SL; Huang LT; Han CB
Medicine (Baltimore); 2018 Aug; 97(35):e12083. PubMed ID: 30170427
[TBL] [Abstract][Full Text] [Related]
7. Xiaoaiping injection combined with chemotherapy for advanced gastric cancer: An updated systematic review and meta-analysis.
Zhou XQ; Chang YZ; Shen CY; Han J; Chang RA
Front Pharmacol; 2022; 13():1023314. PubMed ID: 36249747
[No Abstract] [Full Text] [Related]
8. The combination of apatinib and S-1 for the treatment of advanced gastric cancer in China: A meta-analysis of randomized controlled trials.
Liu Y; Zhou C; Zhang K; Feng Y; Zhang R
Medicine (Baltimore); 2018 Nov; 97(47):e13259. PubMed ID: 30461630
[TBL] [Abstract][Full Text] [Related]
9. Effects of Aidi injection on life quality and incidence of adverse reactions in patients with non-small cell lung cancer compared with traditional chemotherapy: a systematic review and meta-analysis.
Fang Q; Yu B; Xu H; Xu Y
Front Oncol; 2023; 13():1145029. PubMed ID: 37188193
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer: A systematic review and meta-analysis.
Xu B; Wang X; Wang H; Cao L; Ge Y; Yuan B; Gao R; Li J
Front Cell Infect Microbiol; 2022; 12():875225. PubMed ID: 35992176
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and prognosis analyses of apatinib combined with S-1 in third-line chemotherapy for advanced gastric cancer.
Wu Q; Fu Y; Wen W; Xi T; Zhao G
J BUON; 2020; 25(2):987-994. PubMed ID: 32521896
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of apatinib combined with chemotherapy for the treatment of advanced gastric cancer in the Chinese population: a systematic review and meta-analysis.
Cheng H; Sun A; Guo Q; Zhang Y
Drug Des Devel Ther; 2018; 12():2173-2183. PubMed ID: 30034222
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of apatinib combined with radiotherapy in the treatment of advanced pancreatic cancer: a meta-analysis.
Ma Y; Li J; Wen L; Zhang G; Yao X
World J Surg Oncol; 2023 Jun; 21(1):165. PubMed ID: 37264386
[TBL] [Abstract][Full Text] [Related]
14. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Traditional Chinese Medicine Combined with Chemotherapy in the Treatment of Gastric Cancer: A Meta-analysis.
Zhang W; Zhao Y; Liu H; Jing C
Comput Math Methods Med; 2022; 2022():8497084. PubMed ID: 35966237
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis.
Peng D; Cai Y; Chen G; Hou M; Luo X; Dongzhi Z; Xie H; Liu Y
Front Pharmacol; 2023; 14():1101063. PubMed ID: 37153777
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis.
Li Z; Liu Z; Wu Y; Li H; Sun Z; Han C; Zhang X; Zhang J
Thorac Cancer; 2021 Nov; 12(21):2838-2848. PubMed ID: 34622571
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of Apatinib combined with TACE in the treatment of hepatocellular carcinoma: a meta-analysis.
Gong A; Li X
World J Surg Oncol; 2022 Mar; 20(1):69. PubMed ID: 35246145
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of pylorus-preserving gastrectomy for early gastric cancer located in the middle third of the stomach: a meta-analysis].
Du Y; Li WP; Xiong H; Zhang S; Zhou ZY; Deng JP; Zhang JN
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1088-1096. PubMed ID: 33212558
[No Abstract] [Full Text] [Related]
20. The efficacy and safety of apatinib in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis.
Lin H; Weng X; Wu X; Wu L
Transl Cancer Res; 2022 Jun; 11(6):1770-1780. PubMed ID: 35836539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
